secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALLURION TECHNOLOGIES, INC. (ALUR)
CIK:        0001964979
Form:       8-K
Filed at:   2026-03-02T23:59:59+00:00
Accession:  0001193125-26-084412
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allurion receives NYSE delisting notice for non-compliance with equity/market cap standard; intends to appeal
--------------------------------------------------------------------------------

- NYSE notified Allurion it fails Section 802.01B: requires ≥$50M stockholders' equity or ≥$50M market cap on 30-day average.
- Company intends to appeal; shares expected to continue trading on NYSE during the appeal process.
- Recent FDA approval on Feb 20, 2026 cited as catalyst for regaining compliance or relisting on another exchange.
- Also pursuing debt-for-preferred exchange with largest creditor and completed warrant inducement on Feb 24, 2026.
- No guarantee of success; risk of delisting and negative impact on liquidity and capital access if appeal fails.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1964979/000119312526084412/0001193125-26-084412-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1964979/000119312526084412/d39723d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-084412

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer